SPOTLIGHT: Medicaid spends big bucks on antipsychotics for elderly

Medicaid spends more money on antipsychotics than on any other class of drugs. That's partly because nursing homes depend on these drugs to quiet patients with dementia, a use that isn't approved by the FDA--in fact, is warned against because of the risk of severe side effects. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.